Metformin and COVID-19: From cellular mechanisms to reduced mortality

{ 'indexed': {'date-parts': [[2024, 4, 23]], 'date-time': '2024-04-23T09:57:05Z', 'timestamp': 1713866225553}, 'reference-count': 44, 'publisher': 'Elsevier BV', 'issue': '6', 'license': [ { 'start': { 'date-parts': [[2020, 11, 1]], 'date-time': '2020-11-01T00:00:00Z', 'timestamp': 1604188800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.elsevier.com/tdm/userlicense/1.0/'}], 'content-domain': { 'domain': [ 'clinicalkey.jp', 'clinicalkey.com', 'clinicalkey.es', 'clinicalkey.fr', 'clinicalkey.com.au', 'elsevier.com', 'sciencedirect.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2020, 11]]}, 'DOI': '10.1016/j.diabet.2020.07.006', 'type': 'journal-article', 'created': {'date-parts': [[2020, 8, 1]], 'date-time': '2020-08-01T20:07:46Z', 'timestamp': 1596312466000}, 'page': '423-426', 'update-policy': 'http://dx.doi.org/10.1016/elsevier_cm_policy', 'source': 'Crossref', 'is-referenced-by-count': 133, 'title': 'Metformin and COVID-19: From cellular mechanisms to reduced mortality', 'prefix': '10.1016', 'volume': '46', 'author': [{'given': 'A.J.', 'family': 'Scheen', 'sequence': 'first', 'affiliation': []}], 'member': '78', 'reference': [ { 'key': '10.1016/j.diabet.2020.07.006_bib0005', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.diabet.2020.05.001', 'article-title': 'Patients with diabetes are at higher risk for severe illness from ' 'COVID-19', 'author': 'Targher', 'year': '2020', 'journal-title': 'Diabetes Metab'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0010', 'article-title': 'Assessment of risk, severity, mortality, glycemic control and ' 'antidiabetic agents in patients with diabetes and COVID-19: a narrative ' 'review', 'volume': '165', 'author': 'Kumar Singh', 'year': '2020', 'journal-title': 'Diabetes Res Clin Pract'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0015', 'doi-asserted-by': 'crossref', 'first-page': '535', 'DOI': '10.1016/j.dsx.2020.04.044', 'article-title': 'Is diabetes mellitus associated with mortality and severity of ' 'COVID-19? A meta-analysis', 'volume': '14', 'author': 'Kumar', 'year': '2020', 'journal-title': 'Diabetes Metab Syndr'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0020', 'doi-asserted-by': 'crossref', 'first-page': '1500', 'DOI': '10.1007/s00125-020-05180-x', 'article-title': 'Phenotypic characteristics and prognosis of in-patients with COVID-19 ' 'and diabetes: the CORONADO study', 'volume': '63', 'author': 'Cariou', 'year': '2020', 'journal-title': 'Diabetologia'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0025', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.diabres.2020.108186', 'article-title': 'Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood ' 'glucose control should be mandatory', 'volume': '163', 'author': 'Ceriello', 'year': '2020', 'journal-title': 'Diabetes Res Clin Pract'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0030', 'article-title': 'Why is hyperglycemia worsening COVID-19 and its prognosis?', 'volume': '28', 'author': 'Ceriello', 'year': '2020', 'journal-title': 'Diabetes Obes Metab'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0035', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.diabres.2020.108146', 'article-title': 'Should anti-diabetic medications be reconsidered amid COVID-19 ' 'pandemic?', 'volume': '163', 'author': 'Pal', 'year': '2020', 'journal-title': 'Diabetes Res Clin Pract'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0040', 'doi-asserted-by': 'crossref', 'first-page': '486', 'DOI': '10.1111/1753-0407.13047', 'article-title': 'Is the type of diabetes treatment relevant to outcome of COVID-19?', 'volume': '12', 'author': 'Bloomgarden', 'year': '2020', 'journal-title': 'J Diabetes'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0045', 'doi-asserted-by': 'crossref', 'first-page': '221', 'DOI': '10.1007/s00125-019-05039-w', 'article-title': '2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. ' 'A consensus report by the American Diabetes Association (ADA) and the ' 'European Association for the Study of Diabetes (EASD)', 'volume': '63', 'author': 'Buse', 'year': '2020', 'journal-title': 'Diabetologia'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0050', 'doi-asserted-by': 'crossref', 'first-page': '854', 'DOI': '10.1016/S0140-6736(98)07037-8', 'article-title': 'Effect of intensive blood-glucose control with metformin on ' 'complications in overweight patients with type 2 diabetes (UKPDS 34), ' 'UK Prospective Diabetes Study (UKPDS) Group', 'volume': '352', 'author': 'United Kingdom Prospective Diabetes Study Group', 'year': '1998', 'journal-title': 'Lancet'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0055', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.diabet.2020.05.008', 'article-title': 'Prognostic factors in patients with diabetes hospitalized for COVID-19: ' 'findings from the CORONADO study and recent reports', 'author': 'Scheen', 'year': '2020', 'journal-title': 'Diabetes Metab'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0060', 'doi-asserted-by': 'crossref', 'DOI': '10.1111/dom.14134', 'article-title': 'Diabetes, obesity and COVID-19: a complex interplay', 'author': 'Vas', 'year': '2020', 'journal-title': 'Diabetes Obes Metab'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0065', 'doi-asserted-by': 'crossref', 'first-page': 'E736', 'DOI': '10.1152/ajpendo.00124.2020', 'article-title': 'COVID-19 pandemic, coronaviruses, and diabetes mellitus', 'volume': '318', 'author': 'Muniyappa', 'year': '2020', 'journal-title': 'Am J Physiol Endocrinol Metab'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0070', 'doi-asserted-by': 'crossref', 'first-page': '652', 'DOI': '10.1161/CIRCRESAHA.116.308445', 'article-title': 'Anti-inflammatory effects of metformin irrespective of diabetes status', 'volume': '119', 'author': 'Cameron', 'year': '2016', 'journal-title': 'Circ Res'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0075', 'doi-asserted-by': 'crossref', 'first-page': '278', 'DOI': '10.1016/S2213-8587(20)30021-8', 'article-title': 'Metformin to reduce metabolic complications and inflammation in ' 'patients on systemic glucocorticoid therapy: a randomised, ' 'double-blind, placebo-controlled, proof-of-concept, phase 2 trial', 'volume': '8', 'author': 'Pernicova', 'year': '2020', 'journal-title': 'Lancet Diabetes Endocrinol'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0080', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.1007/s13300-020-00830-0', 'article-title': 'COVID-19 and diabetes mellitus: may old anti-diabetic agents become the ' "new philosopher's stone?", 'volume': '11', 'author': 'Penlioglou', 'year': '2020', 'journal-title': 'Diabetes Ther'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0085', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.diabres.2020.108183', 'article-title': 'Metformin in COVID-19: a possible role beyond diabetes', 'volume': '164', 'author': 'Sharma', 'year': '2020', 'journal-title': 'Diabetes Res Clin Pract'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0090', 'article-title': 'Is metformin ahead in the race as a repurposed host-directed therapy ' 'for patients with diabetes and COVID-19?', 'volume': '165', 'author': 'Kumar Singh', 'year': '2020', 'journal-title': 'Diabetes Res Clin Pract'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0095', 'doi-asserted-by': 'crossref', 'first-page': '1577', 'DOI': '10.1007/s00125-017-4342-z', 'article-title': 'The mechanisms of action of metformin', 'volume': '60', 'author': 'Rena', 'year': '2017', 'journal-title': 'Diabetologia'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0100', 'article-title': 'Metformin and COVID-19: a novel deal of an old drug', 'volume': '29', 'author': 'El-Arabey', 'year': '2020', 'journal-title': 'J Med Virol'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0105', 'doi-asserted-by': 'crossref', 'DOI': '10.1111/obr.13084', 'article-title': 'Obesity and COVID-19: the mTOR pathway as a possible culprit', 'author': 'Bolourian', 'year': '2020', 'journal-title': 'Obes Rev'}, { 'issue': '3', 'key': '10.1016/j.diabet.2020.07.006_bib0110', 'doi-asserted-by': 'crossref', 'first-page': '1', 'DOI': '10.3892/wasj.2020.68', 'article-title': 'Inhaled biguanides and mTOR inhibition for influenza and coronavirus ' '(Review)', 'volume': '2', 'author': 'Lehrer', 'year': '2020', 'journal-title': 'World Acad Sci J'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0115', 'article-title': 'A proposed mechanism for the possible therapeutic potential of ' 'metformin in COVID-19', 'volume': '164', 'author': 'Esam', 'year': '2020', 'journal-title': 'Diabetes Res Clin Pract'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0120', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.diabres.2020.108230', 'article-title': 'Metformin, neutrophils and COVID-19 infection', 'volume': '164', 'author': 'Dalan', 'year': '2020', 'journal-title': 'Diabetes Res Clin Pract'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0125', 'doi-asserted-by': 'crossref', 'first-page': '8760', 'DOI': '10.18632/aging.103347', 'article-title': 'Metformin and SARS-CoV-2: mechanistic lessons on air pollution to ' 'weather the cytokine/thrombotic storm in COVID-19', 'volume': '12', 'author': 'Menendez', 'year': '2020', 'journal-title': 'Aging (Albany NY)'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0130', 'doi-asserted-by': 'crossref', 'DOI': '10.1002/jmv.26090', 'article-title': 'Metformin use amid coronavirus disease 2019 pandemic', 'author': 'Kow', 'year': '2020', 'journal-title': 'J Med Virol'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0135', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.diabres.2020.108167', 'article-title': 'COVID-19 and diabetes: is metformin a friend or foe?', 'volume': '164', 'author': 'Ursini', 'year': '2020', 'journal-title': 'Diabetes Res Clin Pract'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0140', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.diabres.2020.108184', 'article-title': 'Comment on “Should anti-diabetic medications be reconsidered amid ' 'COVID-19 pandemic?.”', 'volume': '164', 'author': 'Cure', 'year': '2020', 'journal-title': 'Diabetes Res Clin Pract'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0145', 'article-title': 'Observational study of metformin and risk of mortality in patients ' 'hospitalized with Covid-19', 'volume': '28', 'author': 'Bramante', 'year': '2020', 'journal-title': 'medRxiv'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0150', 'doi-asserted-by': 'crossref', 'first-page': '1399', 'DOI': '10.2337/dc20-0660', 'article-title': 'Clinical characteristics and outcomes of patients with diabetes and ' 'COVID-19 in association with glucose-lowering medication', 'volume': '43', 'author': 'Chen', 'year': '2020', 'journal-title': 'Diabetes Care'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0155', 'doi-asserted-by': 'crossref', 'first-page': '69', 'DOI': '10.4269/ajtmh.20-0375', 'article-title': 'Metformin treatment was associated with decreased mortality in COVID-19 ' 'patients with diabetes in a retrospective analysis', 'volume': '103', 'author': 'Luo', 'year': '2020', 'journal-title': 'Am J Trop Med Hyg'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0160', 'doi-asserted-by': 'crossref', 'first-page': '1068', 'DOI': '10.1016/j.cmet.2020.04.021', 'article-title': 'Association of blood glucose control and outcomes in patients with ' 'COVID-19 and pre-existing type 2 diabetes', 'volume': '31', 'author': 'Zhu', 'year': '2020', 'journal-title': 'Cell Metab'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0165', 'doi-asserted-by': 'crossref', 'first-page': '179', 'DOI': '10.1016/j.diabet.2013.02.006', 'article-title': 'Metformin revisited: a critical review of the benefit-risk balance in ' 'at-risk patients with type 2 diabetes', 'volume': '39', 'author': 'Scheen', 'year': '2013', 'journal-title': 'Diabetes Metab'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0170', 'doi-asserted-by': 'crossref', 'first-page': '50', 'DOI': '10.1186/s13054-019-2346-4', 'article-title': 'Association of preadmission metformin use and mortality in patients ' 'with sepsis and diabetes mellitus: a systematic review and ' 'meta-analysis of cohort studies', 'volume': '23', 'author': 'Liang', 'year': '2019', 'journal-title': 'Crit Care'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0175', 'doi-asserted-by': 'crossref', 'first-page': '149', 'DOI': '10.1007/s00228-019-02786-y', 'article-title': 'Impacts of metformin on tuberculosis incidence and clinical outcomes in ' 'patients with diabetes: a systematic review and meta-analysis', 'volume': '76', 'author': 'Zhang', 'year': '2020', 'journal-title': 'Eur J Clin Pharmacol'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0180', 'doi-asserted-by': 'crossref', 'first-page': '147', 'DOI': '10.1016/S1262-3636(07)70261-6', 'article-title': 'Effect of metformin on survival rate in experimental sepsis', 'volume': '32', 'author': 'Gras', 'year': '2006', 'journal-title': 'Diabetes Metab'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0185', 'doi-asserted-by': 'crossref', 'first-page': 'e2975', 'DOI': '10.1002/dmrr.2975', 'article-title': 'Is metformin poised for a second career as an antimicrobial?', 'volume': '34', 'author': 'Malik', 'year': '2018', 'journal-title': 'Diabetes Metab Res Rev'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0190', 'doi-asserted-by': 'crossref', 'first-page': '646', 'DOI': '10.1111/resp.13486', 'article-title': 'Reduced mortality from lower respiratory tract disease in adult ' 'diabetic patients treated with metformin', 'volume': '24', 'author': 'Mendy', 'year': '2019', 'journal-title': 'Respirology'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0195', 'doi-asserted-by': 'crossref', 'first-page': '69', 'DOI': '10.1186/s12931-019-1035-9', 'article-title': 'Metformin use mitigates the adverse prognostic effect of diabetes ' 'mellitus in chronic obstructive pulmonary disease', 'volume': '20', 'author': 'Ho', 'year': '2019', 'journal-title': 'Respir Res'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0200', 'doi-asserted-by': 'crossref', 'first-page': '473', 'DOI': '10.1111/dom.12854', 'article-title': 'Understanding and overcoming metformin gastrointestinal intolerance', 'volume': '19', 'author': 'Bonnet', 'year': '2017', 'journal-title': 'Diabetes Obes Metab'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0205', 'doi-asserted-by': 'crossref', 'first-page': '1003', 'DOI': '10.14309/ajg.0000000000000691', 'article-title': 'COVID-19 and the digestive system', 'volume': '115', 'author': 'Ma', 'year': '2020', 'journal-title': 'Am J Gastroenterol'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0210', 'doi-asserted-by': 'crossref', 'first-page': '1502', 'DOI': '10.1111/dom.12974', 'article-title': 'Metformin-associated lactic acidosis (MALA): moving towards a new ' 'paradigm', 'volume': '19', 'author': 'Lalau', 'year': '2017', 'journal-title': 'Diabetes Obes Metab'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0215', 'doi-asserted-by': 'crossref', 'DOI': '10.1016/j.diabet.2020.06.003', 'article-title': 'SGLT2 inhibition during the COVID-19 epidemic: friend or foe?', 'author': 'Scheen', 'year': '2020', 'journal-title': 'Diabetes Metab'}, { 'key': '10.1016/j.diabet.2020.07.006_bib0220', 'doi-asserted-by': 'crossref', 'first-page': '457', 'DOI': '10.1016/j.diabet.2018.09.005', 'article-title': 'Effects of SGLT2 inhibitors on systemic and tissue low-grade ' 'inflammation: potential contribution for diabetic complications and ' 'cardiovascular disease', 'volume': '44', 'author': 'Bonnet', 'year': '2018', 'journal-title': 'Diabetes Metab'}], 'container-title': 'Diabetes & Metabolism', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://api.elsevier.com/content/article/PII:S1262363620300987?httpAccept=text/xml', 'content-type': 'text/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://api.elsevier.com/content/article/PII:S1262363620300987?httpAccept=text/plain', 'content-type': 'text/plain', 'content-version': 'vor', 'intended-application': 'text-mining'}], 'deposited': { 'date-parts': [[2021, 3, 27]], 'date-time': '2021-03-27T14:06:12Z', 'timestamp': 1616853972000}, 'score': 1, 'resource': {'primary': {'URL': 'https://linkinghub.elsevier.com/retrieve/pii/S1262363620300987'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2020, 11]]}, 'references-count': 44, 'journal-issue': {'issue': '6', 'published-print': {'date-parts': [[2020, 11]]}}, 'alternative-id': ['S1262363620300987'], 'URL': 'http://dx.doi.org/10.1016/j.diabet.2020.07.006', 'relation': {}, 'ISSN': ['1262-3636'], 'subject': [], 'container-title-short': 'Diabetes & Metabolism', 'published': {'date-parts': [[2020, 11]]}, 'assertion': [ {'value': 'Elsevier', 'name': 'publisher', 'label': 'This article is maintained by'}, { 'value': 'Metformin and COVID-19: From cellular mechanisms to reduced mortality', 'name': 'articletitle', 'label': 'Article Title'}, {'value': 'Diabetes & Metabolism', 'name': 'journaltitle', 'label': 'Journal Title'}, { 'value': 'https://doi.org/10.1016/j.diabet.2020.07.006', 'name': 'articlelink', 'label': 'CrossRef DOI link to publisher maintained version'}, {'value': 'article', 'name': 'content_type', 'label': 'Content Type'}, { 'value': '© 2020 Elsevier Masson SAS. All rights reserved.', 'name': 'copyright', 'label': 'Copyright'}]}